UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials

Vogel, JP; Oladapo, OT; Pileggi-Castro, C; Adejuyigbe, EA; Althabe, F; Ariff, S; Ayede, AI; ... Metin Gülmezoglu, A; + view all (2017) Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials. BMJ Global Health , 2 (3) , Article e000398. 10.1136/bmjgh-2017-000398. Green open access

[thumbnail of e000398.full.pdf]
Preview
Text
e000398.full.pdf - Published Version

Download (338kB) | Preview

Abstract

The scientific basis for antenatal corticosteroids (ACS) for women at risk of preterm birth has rapidly changed in recent years. Two landmark trials-the Antenatal Corticosteroid Trial and the Antenatal Late Preterm Steroids Trial-have challenged the long-held assumptions on the comparative health benefits and harms regarding the use of ACS for preterm birth across all levels of care and contexts, including resource-limited settings. Researchers, clinicians, programme managers, policymakers and donors working in low-income and middle-income countries now face challenging questions of whether, where and how ACS can be used to optimise outcomes for both women and preterm newborns. In this article, we briefly present an appraisal of the current evidence around ACS, how these findings informed WHO's current recommendations on ACS use, and the knowledge gaps that have emerged in the light of new trial evidence. Critical considerations in the generalisability of the available evidence demonstrate that a true state of clinical equipoise exists for this treatment option in low-resource settings. An expert group convened by WHO concluded that there is a clear need for more efficacy trials of ACS in these settings to inform clinical practice.

Type: Article
Title: Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1136/bmjgh-2017-000398
Publisher version: http://dx.doi.org/10.1136/bmjgh-2017-000398
Language: English
Additional information: This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.
Keywords: antenatal corticosteroids, neonatal mortality, preterm birth
UCL classification: UCL
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10055986
Downloads since deposit
1,600Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item